Abstract:Abstract Maintenance of quiescent hematopoietic stem cells (HSCs) is essential for life-long hematopoiesis. A prominent category of HSC quiescence regulators that determine HSC fate by directly interacting with niche-derived growth factors are receptor tyrosine kinases (RTKs). Cbl and Cbl-b are E3 ubiquitin ligases that are directed to activated tyrosine kinases and negatively regulate a number of cellular activation pathways. Previously, we established a conditional Cbl and Cbl-b double knockout (DKO) mouse strain using MMTV-Cre to delete floxed Cbl on a Cbl-b-null background, and identified that Cbl and Cbl-b function redundantly in controlling the growth factor-induced proliferation of HSCs. These DKO mice developed a rapidly fatal myeloproliferative disorder (MPD) accompanied by expansion of the HSC compartment. However, how the negative regulatory functions of Cbl-family proteins are integrated into HSC homeostatic program and the mechanistic basis for their role remain unknown. Here, we utilize mouse models to examine the functional role of Cbl and Cbl-b in regulating HSCs and its potential mechanistic basis. Transplant analyses revealed that DKO HSCs are the disease-initiating cells. However, in vitro serial colony-forming assays showed that DKO HSCs possess a reduced colony-forming ability despite their hyper-proliferative status. Cell cycle analyses demonstrated a smaller pool of quiescent long-term HSCs in DKO mice. Non-responder assays in vivo showed a reduced frequency of functional HSCs in the DKO LSK compartment and serial HSC transplantation demonstrated compromised reconstitution ability of DKO HSCs, especially at the 2nd round of transplantation. Mechanistically, DKO HSCs exhibit sustained signaling in response to c-Kit and FLT3 ligands, especially via p-Akt but also p-Erk and p-S6. The ligand-induced cell surface c-Kit and FLT3 receptor downregulation was slower in DKO HSCs. Furthermore, while c-Kit and FLT3 ligands promote higher proliferation of DKO bone marrow cells, this hyper-proliferation leads to loss of colony-forming potential that is significantly reversed by respective kinase inhibitors. Together, our data reveal a novel and physiologically essential role of Cbl and Cbl-b in the enforcement of HSC quiescence and protection against exhaustion by fine-tuning the signaling pathways downstream of tyrosine kinase-coupled receptors such as c-Kit and FLT3. These findings could have significant implications for hematological neoplasms associated with mutations of Cbl. Disclosures No relevant conflicts of interest to declare.

Ubiquitin Ligases CBL and CBL-B Maintain the Homeostasis and Immune Quiescence of Dendritic Cells

Ablation of Cbl-b and C-Cbl in Dendritic Cells Causes Spontaneous Liver Cirrhosis Via Altering Multiple Properties of CD103+ Cdc1s

Ablation of Cbl-b and C-Cbl in Macrophages Causes Severe Spontaneous Lung Inflammation Via Enhancing the M-CSFR Signaling Pathway

E3 Ligase C-Cbl Regulates Intestinal Inflammation Through Suppressing Fungi-Induced Noncanonical NF-κΒ Activation

Tyrosine Kinase-Directed Ubiquitin Ligases Cbl and Cbl-b Enforce Hematopoietic Stem Cell Quiescence By Negatively Regulating c-Kit and FLT3

The E3 ligase c-Cbl regulates dendritic cell activation.

Cbl and Cbl-b ubiquitin ligases are essential for intestinal epithelial stem cell maintenance

The Inhibitory HVEM-BTLA Pathway Counter Regulates Lymphotoxin Β Receptor Signaling to Achieve Homeostasis of Dendritic Cells

Dlg1 Maintains Dendritic Cell Function by Securing Voltage-Gated K+ Channel Integrity.

Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation

The Kinase Tbk1 Functions in Dendritic Cells to Regulate T Cell Homeostasis, Autoimmunity, and Antitumor Immunity

Genomic deletion of Bcl6 differentially affects conventional dendritic cell subsets and compromises Tfh/Tfr/Th17 cell responses

TAK1-dependent Checkpoint in Dendritic Cell Survival Promotes Immune Homeostasis and Function (111.53)

The transcription factor Zeb1 controls homeostasis and function of type 1 conventional dendritic cells

TSC1-mTOR-controlled Metabolic Epigenetic Crosstalk Underlies DC Control of CD8+T Cell Homeostasis

LKB1 Orchestrates Dendritic Cell Metabolic Quiescence and Anti-Tumor Immunity.

Cbl-b restrains priming of pathogenic Th17 cells via the inhibition of IL-6 production by macrophages

Siglec-H-/- Plasmacytoid Dendritic Cells Protect Against Acute Liver Injury by Suppressing IFN-γ/Th1 Response and Promoting IL-21+ CD4 T Cells

E3 Ubiquitin Ligase Cbl-b Negatively Regulates C-type Lectin Receptor–mediated Antifungal Innate Immunity

Deficiency of Bim in Dendritic Cells Contributes to Overactivation of Lymphocytes and Autoimmunity.